| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eb27d76025e33e165e95b29e469ad3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f8945255723d21b0bf48fe332ce5312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caad690e4761f745bea31df763d0bae3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015 |
| filingDate |
2011-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f13847382be7f4e66d984093d82f33e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7467d49c493729138bd41bd5f68c55e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bdcaa04e88a9f21463e9215fbd290cf |
| publicationDate |
2013-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013216580-A1 |
| titleOfInvention |
Heterologous prime boost vaccination regimen against malaria |
| abstract |
Described are methods for inducing an immune response in a subject against an antigen from a malaria-causing parasite, preferably P. falciparum , the method comprising: (i) administering to a subject a priming composition comprising adjuvanted proteinaceous antigen-comprising circumsporozoite (CS) protein or an immunogenic part thereof from a malaria-causing parasite; (ii) administering to the subject a first boosting composition comprising a recombinant adenovirus vector that comprises nucleic acid encoding CS protein or immunogenic part thereof from a malaria-causing parasite; and (iii) administering to the subject a second boosting composition comprising a recombinant adenovirus vector that comprises nucleic acid encoding CS protein or an immunogenic part thereof from a malaria-causing parasite, wherein either the first boosting composition comprises a recombinant adenovirus vector of serotype 35 (Ad35) and the second boosting composition comprises a recombinant adenovirus of Ad26, or wherein the first boosting composition comprises a recombinant adenovirus vector of Ad26 and the second boosting composition comprises a recombinant adenovirus of Ad35. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472869-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301379-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10400034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562963-B2 |
| priorityDate |
2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |